Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 998

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9
Chunk 998
---

of December 31, 2024, there was approximately $0.5 million unrecognized compensation cost related to unvested RSU’s awards granted.
These costs will be expensed in 2025.

    F-18

MIRA PHARMACEUTICALS, INC.

NOTES TO THE FINANCIAL STATEMENTS

DECEMBER 31, 2024 AND 2023

The
following is RSU activity during the year ended December 31, 2024:

 Schedule
of Restricted Stock Unit Activity

    Number
    of Restricted Shares 

    Outstanding
    as December 31, 2023 
     - 

    RSU’s
    granted 
     500,000 

    Expired 
     - 

    Forfeitures 
     - 

    Outstanding
    as December 31, 2024 
     500,000 

Warrants

In
connection with various transactions and the IPO summarized below, the Company issue stock warrants. Warrant activity for the year ended
December 31, 2024 is summarized below:

SCHEDULE
OF WARRANT ACTIVITY

    Weighted  

    Weighted  
    Average  

    Number
    of  
    Average
    Exercise  
    Remaining
    Contractual  
    Aggregate 

    Warrants  
    Price  
    Term
    (Years)  
    Intrinsic
    Value 
  
    Balance
    Outstanding as January 1, 2023 
     -  
    $-  
     -  
     - 
  
    Granted 
     1,763,570  
    $3.88  
     5.0  
        - 
  
    Balance
    Outstanding as December 31, 2023 
     1,763,570  
    $3.88  
     4.6  
     - 
  
    Granted 
     -  
    $-  
     -  
     - 
  
    Exercised 
     -  
    $-  
     -  
     - 
  
    Balance
    Outstanding as December 31, 2024 
     1,763,570  
    $3.88  
     3.6  
     - 
  
    Exercisable,
    December